Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | VRAYQ | Common Stock | Purchase | $900K | +350K | +267.99% | $2.57* | 481K | May 10, 2022 | See footnote | F2, F3 |
transaction | VRAYQ | Common Stock | Purchase | $2.7M | +1.07M | +221.6% | $2.54* | 1.55M | May 11, 2022 | See footnote | F3, F4 |
holding | VRAYQ | Common Stock | 827K | May 10, 2022 | Direct | F1 |
Id | Content |
---|---|
F1 | Effective March 3, 2022, Mr. Castelein stepped down as the Nominating and Corporate Governance Committee Chair. As such, 1,001 Deferred Stock Units were canceled for no consideration from the original January 3, 2022 grant of 12,521 Deferred Stock Units. The 827,376 total amount of Securities Beneficially Owned reflects the March 3, 2022 cancellation. |
F2 | Reflects average weighted purchase price. Actual purchase prices ranged from $2.46 to $2.60 per share. The reporting person undertakes to provide, upon the request of the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares purchased at each separate price. |
F3 | Shares held by KVP Capital, L.P., an entity controlled by Mr. Castelein. |
F4 | Reflects average weighted purchase price. Actual purchase prices ranged from $2.455 to $2.58 per share. The reporting person undertakes to provide, upon the request of the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares purchased at each separate price. |